• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/28

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

28 Cards in this Set

  • Front
  • Back
These are 10 possible causes of secondary HTN
Primary hyperaldosteronism, pheochromocytoma, renal artery stenosis (renovascular HTN), renal parenchymal disease, coarctation of the aorta, Cushing's, thyroid disease, alcohol, oral contraception, pregnancy-induced HTN
This condition is characterized by hyperplasia or adenoma of the adrenal cortex
Hyperaldosteronism
Hypokalemia and metabolic acidosis may result from this secondary cause of HTN
Hyperaldosteronism
Low potassium, increased aldosterone and decreased renin suggest this diagnosis
Hyperaldosteronism
What percent of pheochromocytomas are maligant?
Ten percent (10%)
50% of patients with this disease have intermittent spells of HTN. The other half have sustained HTN.
Pheochromocytoma patients
These patients have paroxysms of HTN associated with vasoconstriction, pallor and bradycardia
Patients with NE-secreting tumors (pheochromocytomas)
These patients have paroxysms of HTN associated with orthostatic HTN and tachycardia
Patients with E-secreting tumors (pheochromocytomas)
A patient with metanephrines and vanillymandelic acid in the serum or urine may have this disease.
Pheochromocytoma
These are the two causes of renal artery stenosis
Atherosclerosis in older men; fibromuscular hyperplasia in younger women (esp. smokers)
A patient with different renin levels in the left and right renal veins may have this disease
Renal artery stenosis (renovascular HTN)
Hypokalemia is not characteristic of this secondary cause of HTN
Pheochromocytoma
The mechanism of these conditions is increased total blood volume
Primary hyperaldosteronism, Cushing's syndrome, parenchymal disease (with Na retention)
The mechanism of these conditions is increased cardiac output
Hyperthyroidism, hyperkinetic heart syndrome
The mechanism of these conditions is increased peripheral vascular tone
Renal artery stenosis (renovascular HTN), hyperthyroidism, hypothyroidism
These conditions are associated with high renin
Conditions that cause increased peripheral vascular tone
These conditions are associated with low renin
Conditions that cause increased total blood volume
Treatment for low renin conditions
Diuretics
Treatment for high renin conditions
Vasodilators (Angiotensin II is a powerful vasoconstrictor)
Treatment for conditions that cause increased cardiac output
Beta-blockers
A patient with elevated blood pressure in the arms, and decreased BP in the legs may have this disease
Aortic coarctation
A patient with a continuous murmur over the aorta may have this condition
Aortic coarctation
A patient with a CXR showing notching of the ribs may have this disease
Aortic coarctation
How do hyper- and hypothyroidism cause HTN?
Increased thyroid hormone induces synthesis of Na/K pump and beta-1 receptors in the heart. Decreased thyroid hormone results in reduced beta-2 receptors in peripheral arterioles, leading to increased vascular resistance
A patient with HTN who has high angiotensin II, high aldosterone, and low renin levels may have HTN secondary to this
Oral contraceptives (estrogens induce synthesis of angiotensinogen by the liver, leading to increased ang II and aldosterone)
A patient with PIH may present with these symptoms
HTN, rapid weight gain, edema, renal abnormalities (eg, proteinuria)
PIH occurs in this trimester of pregnancy
Third
Major and minor risk factors for atherosclerosis
Major known: Age, gender, family hx, genetic, hyperlipidemia, hypertension, cigarette smoking, diabetes

Minor or uncertain: Postmenopausal estrogen deficiency, obesity, stress, inactivity, high carb intake, EtOH, lipoprotein Lp(a), chlamydia pneumoniae